Page 4 - Microscope Slide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Of treatments over a limited amount of time. one of the things we've started to see is that because the fda will not approve drugs just for anti—ageing, companies are looking for a specific problem to treat. alzheimer's disease is an important one, cardiovascular diseases, kidney diseases, liver diseases — all of these are diseases that are more prevalent as we get older and to the extent that they have a basis of cellular senescence, these agents we're working on could have applicability in other disease areas. what have you got here? that looks like it's connected to an eye? so, yeah, we...

One of the things we've started to see is that because the fda will not approve drugs just for anti—ageing, companies are looking for a specific problem to treat. alzheimer's disease is an important one, cardiovascular diseases, kidney diseases, liver diseases — all of these are diseases that are more prevalent as we get older, and to the extent that they have a basis of cellular senescence, these agents we're working on could have applicability in other disease areas. what have you got here? that looks like it's connected to an eye? so, yeah, we get normal eyes and diseased eyes. we proce...

Will not approve drugs just foranti—ageing, companies are looking for a specific problem to treat. alzheimer's disease is an important one, cardiovascular diseases, kidney diseases, liver diseases — all of these are diseases that are more prevalent as we get older and to the extent that they have a basis of cellular senescence, these agents we're working on could have applicability in other disease areas. what have you got here? that looks like it's connected to an eye? so, yeah, we get normal eyes and diseased eyes. we process them into this wax—like substance, so that we can section th...

Yeah, we get normal eyes and diseased eyes. we can section the eye, a cross—section of it very thinly and put it on a microscope slide. here we are testing different drug candidates on our animal models. so we test in a diseased animal model, does our drug actually inhibit the neovascularisation from forming or get rid of it once it is already formed? a lot of mouse trials have not translated well into humans? we believe it translates relatively well compared to a tumour of cells, and a tumour in a human. quite creepy when you know what it is. yeah, i think it is quite cool. but maybe we are...

On could have applicability in other diseases. what have you got here? that looks like it is connected to an eye? yeah, we get normalised and diseased eyes. we can section the eye, a cross—section of it very thinly and put it on a microscope slide. here we are testing different drug candidates on our animal models. so we test in a diseased animal model, does our drug actually inhibit or get rid of it once it is already formed? a lot of mouse trials have not translated well into humans? we believe it translates relatively well compared to a tumour of cells, and a tumour in a human. quite cree...